Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001415889-25-022324
Filing Date
2025-08-19
Accepted
2025-08-19 17:09:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5879
  Complete submission text file 0001415889-25-022324.txt   7664
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP Denmark 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP Denmark 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Subject) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-93023 | Film No.: 251232830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)